|
Wed, 12/18/2024 - 03:29 |
World Horse Welfare welcomes game-changing breakthrough in Equine Grass Sickness treatment |
World Horse Welfare |
|
Fri, 07/26/2024 - 10:10 |
Sea Slugs: What Can We Learn From Them? |
CarnegieMellon |
|
Fri, 12/17/2021 - 06:41 |
FDA Approves New Treatment for Myasthenia Gravis |
FDA |
|
Tue, 04/13/2021 - 16:56 |
JAXs Timothy Hines receives rare disease research grant from Uplifting Athletes at 2021 Young Investigator Draft |
Jackson Laboratory |
|
Wed, 10/21/2020 - 13:30 |
Scientists identify compound that stimulates muscle cells in mice |
UCLA |
|
Thu, 09/24/2020 - 05:56 |
Cytokinetics Announces Third Annual Communications Fellowship Program Call for Proposals |
Cytokinetics |
|
Wed, 04/08/2020 - 22:21 |
UTSW researchers use snake venom to solve structure of muscle protein |
UTSouthwestern |
|
Tue, 02/04/2020 - 19:26 |
Catalyst Pharmaceuticals Appoints David Ailinger as Vice President, Business Development |
BioFlorida |
|
Thu, 05/30/2019 - 18:50 |
Catalyst Pharmaceuticals Announces Expansion of Firdapse License to Include Japan |
BioFlorida |
|
Sun, 05/05/2019 - 19:26 |
FDA approves first treatment for children with Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder |
FDA |
|
Sat, 04/06/2019 - 15:57 |
Newfound autoimmune syndrome causes muscle pain, weakness |
Washington Univ... |
|
Thu, 03/14/2019 - 13:55 |
Guardians of the synapse: scientists identify a new role for nerve-supporting cells |
Salk Institute |
|
Tue, 02/26/2019 - 03:35 |
Catalyst Pharmaceuticals Announces Publication of Phase 3 Clinical Trial Data for Firdapse for the |
BioFlorida |
|
Fri, 01/04/2019 - 19:02 |
Catalyst Pharmaceuticals Announces Publication of Clinical Data from the Investigator-Sponsored Phas |
BioFlorida |
|
Thu, 11/29/2018 - 18:39 |
FDA Approves Firdapse (Amifampridine) for the Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) |
BioFlorida |
|
Wed, 11/28/2018 - 15:22 |
FDA approves first treatment for Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder |
FDA |
|
Tue, 04/24/2018 - 09:42 |
Myasthenia Gravis Foundation annual conference set for May 12 |
Michigan State ... |
|
Wed, 02/14/2018 - 00:53 |
West Midlands women call for South Asian families to tackle impact of muscular dystrophy |
Muscular Dystro... |
|
Mon, 02/05/2018 - 02:36 |
DEEP OSCILLATION® Proves Effective At The Neuromuscular Centre For Muscular Dystrophy |
PhysioPod UK LTD |
|
Thu, 11/30/2017 - 04:07 |
New Publication Summarizes Phase 1 Studies of CK-2127107 Showing Tolerability and Amplification of Skeletal Muscle Response to Nerve Activation |
Cytokinetics |
|
Sun, 11/19/2017 - 23:52 |
ALS caused by Muscle/Nerve Communication Error |
SapienzaUniv |
|
Wed, 11/01/2017 - 05:00 |
Progress for NHS as avoidable emergency hospital admissions for people with muscle-wasting conditions dramatically reduced |
Muscular Dystro... |
|
Mon, 08/21/2017 - 09:05 |
European Commission Grants New Indication for Soliris (Eculizumab) for the Treatment of Patients with Refractory Generalized Myasthenia Gravis (gMG) |
Alexion |
|
Wed, 07/05/2017 - 06:02 |
Cytokinetics Announces Baseline Data From First Cohort of Phase 2 Clinical Trial of CK-2127107 in Patients With SMA |
Cytokinetics |
|
Sun, 06/04/2017 - 23:53 |
Young at Heart: Restoring Cardiac Function with a Matrix Molecule |
WeizmannInstitute |
